| Are gender differences important for the clinical effects of antidepressants? MG Hildebrandt, EW Steyerberg, KB Stage, J Passchier, ... American Journal of Psychiatry 160 (9), 1643-1650, 2003 | 164 | 2003 |
| Delayed 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study BA Blomberg, A Thomassen, RAP Takx, MG Hildebrandt, JA Simonsen, ... Journal of Nuclear Cardiology 21 (3), 588-597, 2014 | 96 | 2014 |
| [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective … MG Hildebrandt, O Gerke, C Baun, K Falch, JA Hansen, ZA Farahani, ... Journal of Clinical Oncology 34 (16), 1889-1897, 2016 | 76 | 2016 |
| Gender and depression: a study of severity and symptomatology of depressive disorders (ICD‐10) in general practice MG Hildebrandt, KB Stage, P Kragh‐Soerensen Acta Psychiatrica Scandinavica 107 (3), 197-202, 2003 | 70 | 2003 |
| Gender differences in severity, symptomatology and distribution of melancholia in major depression MG Hildebrandt, KB Stage, P Kragh-Soerensen Psychopathology 36 (4), 204-212, 2003 | 68 | 2003 |
| Hybrid PET/MRI in major cancers: a scoping review A Morsing, MG Hildebrandt, MH Vilstrup, SE Wallenius, O Gerke, ... European journal of nuclear medicine and molecular imaging 46, 2138-2151, 2019 | 40 | 2019 |
| Utility of 18FDG-PET/CT in breast cancer diagnostics–a systematic review K Warning, MG Hildebrandt, B Kristensen, M Ewertz Dan Med Bull 58 (7), A4289, 2011 | 32 | 2011 |
| Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules—a literature review SE Dahlsgaard-Wallenius, MG Hildebrandt, A Johansen, MH Vilstrup, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 584-591, 2021 | 29 | 2021 |
| FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact M Vogsen, JD Jensen, IY Christensen, O Gerke, AMB Jylling, LB Larsen, ... Breast Cancer Research and Treatment 185, 145-153, 2021 | 23 | 2021 |
| A role of FDG-PET/CT for response evaluation in metastatic breast cancer? MG Hildebrandt, M Naghavi-Behzad, M Vogsen Seminars in Nuclear Medicine 52 (5), 520-530, 2022 | 22 | 2022 |
| Sentinel lymph node mapping in early-stage cervical cancer–a national prospective multicenter study (SENTIREC trial) SE Sponholtz, O Mogensen, MG Hildebrandt, D Schledermann, E Parner, ... Gynecologic Oncology 162 (3), 546-554, 2021 | 22 | 2021 |
| Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy JA Hansen, M Naghavi-Behzad, O Gerke, C Baun, K Falch, S Duvnjak, ... PLoS One 16 (11), e0260066, 2021 | 21 | 2021 |
| FDG-PET/CT for response monitoring in metastatic breast cancer: the feasibility and benefits of applying PERCIST M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann, TA Alamdari, ... Diagnostics 11 (4), 723, 2021 | 18 | 2021 |
| FDG-PET/CT for response monitoring in metastatic breast cancer: Today, tomorrow, and beyond MG Hildebrandt, JF Lauridsen, M Vogsen, J Holm, MH Vilstrup, PE Braad, ... Cancers 11 (8), 1190, 2019 | 17 | 2019 |
| Response monitoring in metastatic breast Cancer: a prospective study comparing 18F-FDG PET/CT with conventional CT M Vogsen, F Harbo, NM Jakobsen, HJ Nissen, SE Dahlsgaard-Wallenius, ... Journal of Nuclear Medicine 64 (3), 355-361, 2023 | 16 | 2023 |
| Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT M Naghavi-Behzad, M Vogsen, RM Vester, MMB Olsen, H Oltmann, ... British Journal of Cancer 126 (9), 1271-1279, 2022 | 15 | 2022 |
| Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study M Vogsen, JD Jensen, O Gerke, AMB Jylling, JT Asmussen, ... EJNMMI research 11, 1-11, 2021 | 14 | 2021 |
| Perspective of patients with metastatic breast cancer on electronic access to scan results: mixed methods study C Baun, M Vogsen, MK Nielsen, PF Høilund-Carlsen, MG Hildebrandt Journal of Medical Internet Research 22 (2), e15723, 2020 | 14 | 2020 |
| Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review S Kavan, TA Kruse, M Vogsen, MG Hildebrandt, M Thomassen Cancer and Metastasis Reviews 41 (2), 433-446, 2022 | 12 | 2022 |
| Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI) I Fasterholdt, T Kjølhede, M Naghavi-Behzad, T Schmidt, ... International Journal of Technology Assessment in Health Care 38 (1), e74, 2022 | 12 | 2022 |
